Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

The study, which was simultaneously published in Circulation and presented as a Late-Breaking Clinical Trial at the American Heart Association Scientific Sessions, marked a significant step toward ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...

N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

New trial shows stem cells prevent heart failure after heart attack, offering hope for cardiac recovery. Keep reading.

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...